Andrew McGarry

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Andrew McGarry, Michael McDermott, Karl Kieburtz et al. · Neurology · 2016 · 135 citations · Full text

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Andrew McGarry, Shane Rosanbalm, Mika Leinonen et al. · The Lancet Neurology · 2023 · 110 citations

Untreated Parkinson, Neurodegenerative Diseases, Parkinson Disease +5

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 104 citations

Neurodegenerative Diseases, Medicine, Psychotropic Medication +6

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial

Samuel Frank, Claudia Testa, David Stamler et al. · Publisher · 2016 · 44 citations

Neurodegenerative Diseases, Pharmacology, Degenerative Disease +2

Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot study

Andrew McGarry, John Gaughan, Cory Hackmyer et al. · Scientific Reports · 2020 · 38 citations · Full text